Check out which companies are making headlines before the bell:
Pfizer — The drugmaker missed estimates by a penny a share, with adjusted profit of 61 cents per share. Revenue was in line with estimates. Pfizer also lowered its full-year forecast, due to the discontinuation of a lipid-lowering drug that will shave an estimated four cents per share off current-quarter earnings.
Coach — The handbag maker matched estimates with adjusted quarterly profit of 45 cents per share. Revenue came in below forecasts. Coach did maintain its prior full-year forecast.
Archer Daniels Midland — The grain processor beat estimates by 13 cents a share, with adjusted quarterly profit of 59 cents per share. Revenue fell short of Street forecasts. The company said it has worked through a challenging environment during the first half of the year and that its markets are now showing improvement.
Occidental Petroleum — The energy producer lost 15 cents per share for its latest quarter, but revenue came in above estimates.
Apple — A UBS survey is finding strong interest for the iPhone 7 in the United States, but not as much in China compared to the iPhone 6 or 6s models.
Wells Fargo — The bank agreed to pay $50 million to settle a case involving home appraisal feels for homeowners who had defaulted on their mortgages. A court must still approve the settlement.
Anadarko Petroleum — Anadarko lost 89 cents per share for its latest quarter, wider than the 57 cent loss forecast by analysts. Revenue was also below estimates, on the continuing weakness in energy prices.
Viacom — Viacom named Bob Bakish as its new acting chief executive officer, replacing the current acting CEO Tom Dooley. Bakish has been the CEO of Viacom's International Media Networks unit.
L Brands — L Brands said its October comparable-store sales are expected to be up one percent, with the Bath & Body Works division posting a six percent increase and Victoria's Secret reporting a two percent drop. The apparel maker also said third-quarter earnings would come in at about 40 cents per share, compared to previous guidance of 40 cents to 45 cents a share.
Valeant Pharmaceuticals — Former Valeant CEO Michael Pearson and ex-CFO Howard Schiller are the subjects of a U.S. criminal probe, according to a Bloomberg report. The drugmaker issued a comment that did not specifically address the specifics in that story, but did say it had previously disclosed that it was the subject of a probe by U.S. attorneys and that it was fully cooperating.
Tenet Healthcare — Tenet reported quarterly profit of 16 cents per share, missing estimates by three cents a share. The hospital operator's revenue did exceed forecasts. The company also lowered its full-year revenue and profit forecasts.
Sony — Sony reporting a nearly 86 percent drop in profit for its fiscal second quarter compared to a year earlier as its bottom line was impacted by a stronger yen.
BlackBerry — BlackBerry became a "Tier One" supplier for automaker Ford Motor, meaning that it supplies products directly to Ford without the use of a middleman. BlackBerry — once known as a smartphone maker — is now remaking itself as a software provider.
Johnson Controls — The stock was added to the "Conviction Buy" list at Goldman Sachs, following the completion of its spin-off of its Adient unit. Adient is a maker of automobile seating components.
Royal Dutch Shell — Shell's profit rose 18 percent compared to a year earlier, beating analysts' estimates, but the oil producer also lowered 2017 capital spending plans.
BP — BP profits fell by nearly half from a year ago during its third quarter, and the company also cut its 2016 capital spending plans by another $1 billion in the wake of weak oil prices. The latest results did, however, beat analysts' forecasts.